Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...

CVS (operating in Hawaii as Longs Drugs) is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment ...

several companies created EpiPen substitutions and the Food and Drug Administration approved the first generic alternative, but EpiPen had name-brand recognition. Speaking with PEOPLE at the time ...

People or entities who purchased EpiPen® or generic EpiPen directly from Mylan or Teva, for resale, at any time during the period from March 13, 2014, until the date on which the Court entered ...

A backlash against the hugely increased price of its EpiPen product has led Mylan to announce the launch of a generic version. The company has become engulfed in controversy around its US EpiPen ...

Epinephrine has been used since 1901 and is ... As a result of the outcry, Mylan began selling an “authorized generic” for ...

Epinephrine 0.15mg (1:2000); prefilled auto-injector; contains sulfites. Epinephrine acts on both alpha- and beta-adrenergic receptors. Through its action on alpha-adrenergic receptors ...

The company has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) — a critical regulatory step. This product is now ready to be converted into a finished drug product.

There's a very good reason why the EpiPen's 500% price increase drew so much attention, even though there are other emergency auto-injecting devices available that can be used to treat severe ...

Mumbai-based Glenmark Pharmaceuticals announced on Thursday that it has launched the generic version of Epinephrine injection ...